Table 1.
Binding affinities (kcal/mol) of the compounds that were selected for further investigation.
Compound | Classification | Glide energies (kcal/mol) |
---|---|---|
Ritonavir | Protease inhibitor | −71.5 |
Saquinavir | Protease inhibitor | −77.7 |
Lopinavir | Protease inhibitor | −56.2 |
Indinavir | Protease inhibitor | −52.0 |
Nelfinavir | Protease inhibitor | −65.2 |
Darunavir | Protease inhibitor | −58.2 |
Simeprevir | Protease inhibitor | −59.4 |
Remdesivir | Nucleotide analog | −58.0 |
Amikacin | Antibiotic | −64.5 |
Ceftazidime | Antibiotic | −60.5 |
Baricitinib | Janus kinase inhibitor | −48.8 |
Suramin | Antiparasitic | −66.3 |
Hypericin | Anthraquinone derivative | −51.7 |
Ebselen | Organoselenium drug | −32.2 |
Ivermectin | Anti-parasitic agent | −40.7 |
SRT2104 | Sirtuin activator | −60.5 |
SRT1720 | Sirtuin activator | −60.5 |
D,L-Sulforaphane glutathione | Isothiocyanate analog | −61.7 |
(-)-Epicatechin gallate | Natural flavonoid compound | −64.1 |
Quercitrin | OliveNetTM | −60.7 |
β-Hydroxy verbascoside | OliveNetTM | −71.1 |
β-Hydroxy acteoside | OliveNetTM | −67.7 |
Isoacteoside | OliveNetTM | −75.1 |
Verbascoside | OliveNetTM | −76.3 |
Oxidized verbascoside | OliveNetTM | −71.2 |
Quercetin 3-O-rutinoside | OliveNetTM | −77.0 |
Hesperidin | OliveNetTM | −64.0 |
Rutin | OliveNetTM | −69.3 |
Luteolin-7,4-O-diglucoside | OliveNetTM | −66.3 |
Cyanidin-3-O-glucoside | OliveNetTM | −62.7 |